Stocksigma LogoStocksigma Logo

Prism Medico and Pharmacy Reports Nil Debt Obligations for Q3 FY27

Prism Medico and Pharmacy Limited has submitted a regulatory disclosure under SEBI LODR Regulation 57(4) confirming that it has no non-convertible

Prism Medico and Pharmacy Reports Nil Debt Obligations for Q3 FY27

Prism Medico and Pharmacy Ltd 路 Others (Uncategorized) 路 30 Sept 2026, 9:04 pm

Prism Medico and Pharmacy Reports Nil Debt Obligations for Q3 FY27 Prism Medico and Pharmacy Limited has submitted a regulatory disclosure under SEBI LODR Regulation 57(4) confirming that it has no non-convertible securities with interest, dividend, or principal obligations payable during the quarter spanning 1st Oct'26 to 31st Dec'26. Consequently, the company has zero scheduled debt service or redemption cash outflows related to non-convertible securities for the period.

Original exchange filing (PDF)

More announcements from Prism Medico and Pharmacy Ltd

All Prism Medico and Pharmacy Ltd announcements